{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:11:54Z","timestamp":1780528314707,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jocn.2022.03.001","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T22:50:03Z","timestamp":1646866203000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evaluation of circulating endothelial progenitor cells and the severity of transient ischemic attack"],"prefix":"10.1016","volume":"99","author":[{"given":"Wang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.jocn.2022.03.001_b0005","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1212\/WNL.0000000000001665","article-title":"Prevalence, knowledge, and treatment of transient ischemic attacks in China","volume":"84","author":"Wang","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jocn.2022.03.001_b0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1747493017694392","article-title":"Stroke care quality in china: substantial improvement, and a huge challenge and opportunity","volume":"12","author":"Wang","year":"2017","journal-title":"Int J Stroke"},{"issue":"6","key":"10.1016\/j.jocn.2022.03.001_b0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.phrs.2019.04.017","article-title":"Endothelial progenitor cells: Potential novel therapeutics for ischaemic stroke","volume":"144","author":"Bayraktutan","year":"2019","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.jocn.2022.03.001_b0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s13770-021-00366-9","article-title":"Role of stromal cell-derived factor-1 in endothelial progenitor cell-mediated vascular repair and regeneration","volume":"18","author":"Li","year":"2021","journal-title":"Tissue Eng Regen Med"},{"issue":"5","key":"10.1016\/j.jocn.2022.03.001_b0025","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1177\/0300060519827173","article-title":"The stromal cell-derived factor-1\u03b1(SDF-1\u03b1)\/cysteine-X-cysteine chemokine receptor 4 (CXCR4) axis: a possible prognostic indicator of acute ischemic stroke","volume":"47","author":"Huang","year":"2019","journal-title":"J Int Med Res"},{"issue":"3","key":"10.1016\/j.jocn.2022.03.001_b0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10072-017-3143-y","article-title":"Mobilization of endothelial progenitor cell in patients with acute ischemic stroke","volume":"39","author":"Deng","year":"2018","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.jocn.2022.03.001_b0035","first-page":"47","article-title":"The role of endothelial progenitor cells in transient ischemic attack patients for future cerebrovascular events","volume":"21","author":"Meamar","year":"2016","journal-title":"J Res Med Sci"},{"issue":"4","key":"10.1016\/j.jocn.2022.03.001_b0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/svn-2017-000088","article-title":"Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial","volume":"2","author":"Wangqin","year":"2017","journal-title":"Stroke Vasc Neurol"},{"issue":"9479","key":"10.1016\/j.jocn.2022.03.001_b0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)66702-5","article-title":"A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jocn.2022.03.001_b0050","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s12015-020-10064-z","article-title":"Characterization and functional assessment of endothelial progenitor cells in ischemic stroke patients","volume":"17","author":"Kukumberg","year":"2021","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"10.1016\/j.jocn.2022.03.001_b0055","doi-asserted-by":"crossref","first-page":"C572","DOI":"10.1152\/ajpcell.00330.2003","article-title":"Endothelial progenitor cells for postnatal vasculogenesis","volume":"287","author":"Asahara","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.jocn.2022.03.001_b0060","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11011-017-9953-z","article-title":"Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke","volume":"32","author":"Xue","year":"2017","journal-title":"Metab Brain Dis"},{"issue":"6","key":"10.1016\/j.jocn.2022.03.001_b0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tcm.2018.10.010","article-title":"The therapeutic and diagnostic role of exosomes in cardiovascular diseases","volume":"29","author":"Zamani","year":"2019","journal-title":"Trends Cardiovasc"},{"issue":"5","key":"10.1016\/j.jocn.2022.03.001_b0070","doi-asserted-by":"crossref","first-page":"C664","DOI":"10.1152\/ajpcell.00200.2018","article-title":"Revascularization and endothelial progenitor cells in stroke","volume":"315","author":"Esquiva","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.jocn.2022.03.001_b0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2020.06.002","article-title":"Endothelial progenitor cells predict long-term outcome in patients with coronary artery disease: Ten-year follow-up of the PROCREATION extended study","volume":"318","author":"Pelliccia","year":"2020","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.jocn.2022.03.001_b0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/1573403X14666180726112303","article-title":"Endothelial regenerative capacity and aging: influence of diet, exercise and obesity. Curr","volume":"14","author":"Ross","year":"2018","journal-title":"Cardiol Rev"},{"issue":"4","key":"10.1016\/j.jocn.2022.03.001_b0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jdi.12310","article-title":"Decreased levels of circulating CD34+ cells are associated with coronary heart disease in Japanese patients with type 2 diabetes","volume":"6","author":"Makino","year":"2015","journal-title":"J Diabetes Investig"},{"issue":"2","key":"10.1016\/j.jocn.2022.03.001_b0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.08.026","article-title":"Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients","volume":"24","author":"Chen","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.jocn.2022.03.001_b0095","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s12035-015-9645-9","article-title":"Elevated serum levels of CXC chemokine ligand-12 are associated with unfavorable functional outcome and mortality at 6-month follow-up in chinese patients with acute ischemic stroke","volume":"54","author":"Cheng","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.jocn.2022.03.001_b0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1567202615666180611120546","article-title":"Statins therapy is associated with increased populations of early endothelial progenitor (CD133+\/VEGFR2+) and endothelial (CD34-\/CD133- \/VEGFR2+) cells in patients with acute ischemic stroke","volume":"15","author":"Golab-Janowska","year":"2018","journal-title":"Curr Neurovasc Res"},{"key":"10.1016\/j.jocn.2022.03.001_b0105","doi-asserted-by":"crossref","unstructured":"Pan Y, Chen W, Wang Y, et al. Association between ABCB1 polymorphisms and outcomes of clopidogrel treatment in patients with minor stroke or transient ischemic attack: secondary analysis of a randomized clinical trial. JAMA Neurol 2019;76(5):552\u2013560.","DOI":"10.1001\/jamaneurol.2018.4775"},{"key":"10.1016\/j.jocn.2022.03.001_b0110","unstructured":"Nizar D, Amine MM, Aissi M, Machraoui R, Adel S, Bel Haj Ali K, et al. External validations of the ABCD2 score in prediction of stroke risk after transient ischemic attack: a Tunisian hospital-based cohort study. Int J Neurosci 2020;16(10):1\u20137."},{"issue":"45","key":"10.1016\/j.jocn.2022.03.001_b0115","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.2174\/1381612825666191029103756","article-title":"Risk factors of recurrent ischemic events after acute noncardiogenic ischemic stroke","volume":"25","author":"Zhang","year":"2020","journal-title":"Curr Pharm Des"},{"issue":"8","key":"10.1016\/j.jocn.2022.03.001_b0120","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamaneurol.2020.1326","article-title":"Prognosis of asymptomatic intracranial stenosis in patients with transient ischemic attack and minor stroke","volume":"77","author":"Hurford","year":"2020","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.jocn.2022.03.001_b0125","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1161\/STROKEAHA.115.008685","article-title":"CHANCE investigators. soluble CD40L is a useful marker to predict future strokes in patients with minor stroke and transient ischemic attack","volume":"46","author":"Li","year":"2015","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jocn.2022.03.001_b0130","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/ATVBAHA.119.313741","article-title":"CHANCE investigators. homocysteine level predicts response to dual antiplatelet in women with minor stroke or transient ischemic attack: subanalysis of the CHANCE trial","volume":"40","author":"Li","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9558","key":"10.1016\/j.jocn.2022.03.001_b0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(07)60150-0","article-title":"Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack","volume":"369","author":"Johnston","year":"2007","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jocn.2022.03.001_b0140","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S1474-4422(16)30236-8","article-title":"Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies","volume":"15","author":"Kelly","year":"2016","journal-title":"Lancet Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822000935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822000935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:30:36Z","timestamp":1760823036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822000935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":28,"alternative-id":["S0967586822000935"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.03.001","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of circulating endothelial progenitor cells and the severity of transient ischemic attack","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}